F
$ Value
$80K
Shares
6,277
Price
$13
Filed
Feb 12
Insider
Name
Basta Steven L
Title
President and CEO
CIK
0001417397
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-10
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
373,315
Footnotes
Represents shares issued upon vesting of performance stock units granted to the reporting person on April 3, 2025 based on the achievement of performance criteria determined to be satisfied on February 10, 2026. | Includes 2,410 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in January 2026. | Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.
Filing Info
Basta Steven L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | PHAT | A | $0 |
| 2026-02-10 | PHAT | F | $80K |
| 2026-01-02 | PHAT | A | $0 |
| 2026-01-02 | PHAT | A | $0 |
| 2025-12-17 | PHAT | A | $0 |
| 2025-12-17 | PHAT | F | $484K |
| 2025-12-12 | VYNE | A | $0 |
| 2025-11-28 | PHAT | M | $0 |
| 2025-11-28 | PHAT | F | $756K |
| 2025-11-28 | PHAT | M | $0 |
Other Insiders at PHAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
|
— | — | 2026-02-10 |
|
Basta Steven L
President and CEO
|
— | — | 2026-02-10 |
| Parikh Asit | — | — | 2026-03-10 |
|
Breedlove Robert Charles
Principal Accounting Officer
|
— | — | 2026-02-27 |